Skip to main content
All lobbying clients

ROCKET PHARMACEUTICALS, INC.

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceutical company seeking gene therapy for rare diseases

$140,000 Reported spend
7 Filings counted
1 Outside firm hired
0 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (63801), filed by the registrant listed below.

 Who filed for this client 1

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 2 years
  • 2026 $30,000 3 filings
  • 2025 $110,000 4 filings
 Recent filings 7 total
Q3 reportNo activity
THE KPM GROUP DC LLC
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View → Q2 reportNo activity
THE KPM GROUP DC LLC
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 19, 2026
View → Q1 reportNo activity
THE KPM GROUP DC LLC
1st Quarter 2026 (Jan 1 - Mar 31) · $30,000 income · posted Apr 20, 2026
View → Q4 reportNo activity
THE KPM GROUP DC LLC
4th Quarter 2025 (Oct 1 - Dec 31) · $30,000 income · posted Jan 14, 2026
View → Q3 reportNo activity
THE KPM GROUP DC LLC
3rd Quarter 2025 (July 1 - Sep 30) · $30,000 income · posted Oct 13, 2025
View → Q2 reportNo activity
THE KPM GROUP DC LLC
2nd Quarter 2025 (Apr 1 - June 30) · $30,000 income · posted Jul 17, 2025
View → Q1 reportNo activity
THE KPM GROUP DC LLC
1st Quarter 2025 (Jan 1 - Mar 31) · $20,000 income · posted Apr 21, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem